Specific adverse events are associated with response to exemestane therapy in postmenopausal breast cancer patients: Results from the TEAMIIA study (BOOG2006-04)

Fontein, D.B.Y.; Charehbili, A.; Nortier, J.W.R.; Putter, H.; Kranenbarg, E.M.K.; Kroep, J.R.; ... ; Velde, C.J.H. van de (2017)

Article / Letter to editor

• Breast cancer
• Adverse events
• Aromatase inhibitors
• Hot flushes

• All authors: Fontein, D.B.Y.; Charehbili, A.; Nortier, J.W.R.; Putter, H.; Kranenbarg, E.M.K.; Kroep, J.R.; Linn, S.C.; Velde, C.J.H. van de
• Date: 2017-04-30
• Journal: EJSO - European Journal of Surgical Oncology
• Volume: 43
• Issue: 4
• Pages: 619 - 624
• DOI: doi:10.1016/j.ejso.2016.07.146